Construct validity and descriptive validity of somatoform disorders in light of proposed changes for the DSM-5

https://doi.org/10.1016/j.jpsychores.2012.09.015Get rights and content

Abstract

Objective

Current diagnostic criteria for somatoform disorders demand revisions due to their insufficient clinical as well as scientific usability. Various psychological and behavioral characteristics have been considered for the proposed new category Somatic Symptom Disorder (SSD). With this study, we were able to jointly assess the validity of these variables in an inpatient sample.

Methods

Using a cross-sectional design, we investigated N = 456 patients suffering from somatoform disorder, anxiety, or depression. Within one week after admission to the hospital, informed consent was obtained and afterwards, a diagnostic interview and a battery of self-report questionnaires were administered. Logistic regression analyses were performed to determine which variables significantly add to construct and descriptive validity.

Results

Several features, such as somatic symptom severity, health worries, health habits, a self-concept of being weak, and symptom attribution, predicted physical health status in somatization. Overall, our model explained about 50% of the total variance. Furthermore, in comparison with anxious and depressed patients, health anxiety, body scanning, and a self-concept of bodily weakness were specific for DSM-IV somatoform disorders and the proposed SSD.

Conclusions

The present study supports the inclusion of psychological and behavioral characteristics in the DSM-5 diagnostic criteria for somatoform disorders. Based on our results, we make suggestions for a slight modification of criterion B to enhance construct validity of the Somatic Symptom Disorder.

Introduction

For a long time, revisions for somatoform disorders have been demanded since current diagnostic criteria are insufficient for therapeutic as well as scientific use [1], [2], [3], [4], [5]. Different changes have been proposed, such as less restrictive time criteria or the addition of psychosocial symptoms, such as health care utilization, catastrophizing, or a self-concept of being weak [6], [7], [8], [9]. Issues concerning diagnostic validity and clinical utility should be considered in these revisions [10], [11], [12]. The current diagnosis proposed is the Somatic Symptom Disorder (SSD) (updated April 27, 2012; http://www.dsm5.org/ProposedRevision/Pages/proposedrevision.aspx?rid=368). For this new category, medically unexplained symptoms (MUS) are no longer required and somatic complaints have had to be present for at least 6 months. A major revision is the addition of positive criteria (criterion B): concerns about the symptoms' medical seriousness, elevated health anxiety as well as excessive time or energy devoted to the complaints. In the following we give a brief overview of the current status concerning construct validity and descriptive validity of somatization.

Construct validity is given when a diagnosis has an empirically supported theoretical framework that ideally explains its development and maintenance. In the current DSM-IV diagnostic criteria, no existing biopsychosocial model of somatization is reflected [13] even though cognitive-behavioral models of somatization provide useful tools for research and therapy [13], [14], [15]. All models postulate the interaction of various cognitive, behavioral, and physiological factors for the perpetuation of symptoms. In brief, physiological disturbances and emotional arousal produce symptoms that draw bodily attention. If these are attributed to an organic origin, several psychological processes, such as illness worry or catastrophizing may follow, leading to increased illness behavior (help seeking, avoidance, expression of symptoms) and a difference in how symptoms are presented towards the environment (disability, distress, social response).

Patients suffering from somatization show substantial functional impairment [16], [17]. Abnormal illness behavior, such as increased disability days and health care utilization [18], [19], [20], [21], [22], [23], [24], pronounced expression of symptoms [19], [21], or body scanning [19], is present even though versatile [8]. Furthermore, somatization is associated with more catastrophic interpretations of somatic complaints [8], [25], [26]. Patients exhibit a stronger self-concept of physical weakness, higher scores in illness anxiety, and consider themselves more vulnerable to somatic diseases [7], [27], [28]. Greater somatic symptom attribution, which is related to greater impairment than attributing symptoms to psychological causes, has often been found [21], [29], [30], [31], [32]. On the other hand, Hiller and colleagues [33] showed that somatoform patients equally attributed their symptoms to mental/emotional problems and somatic disease.

Descriptive validity is given when a disorder's diagnostic criteria are specific and can be clearly differentiated from others. The well documented high comorbidity of somatoform disorders with depression and anxiety [34], [35], [36] raises the question of diagnostic overlap and increases the demand for more specific criteria for somatization [23]. In the following, findings for psychosocial characteristics included in the proposed revisions for DSM-5, namely SSD's criterion B, are briefly outlined.

Illness worry and catastrophizing have been shown to be increased in somatoform patients compared to patients suffering from other mental disorders [7], [26], [27], [37], [38]. They appear to be especially relevant for immediate and long-term outcome and therefore be valid diagnostic criteria. On the other hand, often no differences were found [7], [39], [40], [41]. Whether a self-concept of bodily weakness is specific for somatization or it is more a result of impairment in general still needs to be investigated [7], [27]. Two promising aspects of illness behavior, body scanning and health care utilization, yield contradictory results. Some indicate specificity [6], [24], [36], [42], [43], [44], [45], others found no difference in illness behavior between somatoform and other patients [19], [24], [46]. Organic attributions as part of previous suggestions for DSM-5 appears to be a promising construct as well. Subjects with somatic complaints exhibited pronounced somatic illness attribution in numerous studies [6], [20], [21], [31] where as in depression and anxiety more psychological attributions can be found [20], [21], [31].

The current literature indicates that there is a deep need to add specific symptoms to the pure existence of physical complaints in order to increase construct and descriptive validity of somatoform diagnoses. As Rief and colleagues [6] pointed out, psychological features should be evaluated together in a study to assess their validity. Aiming at an empirical evaluation of the proposed changes, we conducted a large prospective, diagnostic study to investigate psychological features that might enhance diagnostic validity of somatoform disorders. The current paper focuses on construct validity and descriptive validity; results regarding predictive validity and clinical utility will be reported elsewhere. Based on the current evidence, we tested the following hypotheses:

  • 1)

    Compared to the current diagnostic criteria, additional psychosocial variables (e. g., health anxiety, self-concept of being weak, somatic attribution, illness behavior) will add significantly to the explained variance of self-rated physical health status in somatoform patients (construct validity).

  • 2)

    Psychosocial features will be specific for somatoform disorders when compared with anxiety and depressive patients (descriptive validity).

Section snippets

Sample

The study total sample consisted of 456 inpatients at a psychosomatic clinic in Germany diagnosed with at least one psychiatric disorder. In order to be considered for inpatient treatment, patients have to be chronically ill, present with comorbid diagnoses, and/or treatment-resistant in an outpatient setting. Mostly, the patients have been in outpatient treatment prior to admission, which did not result in sufficient improvement. Somatoform disorders were diagnosed in n = 332 patients (SOMS) and

Sample characteristics

Groups were matched on all sociodemographic variables (see Table 1). Somatoform patients had a mean age of 45.3 years, 63% were women, and all were German. The control group had a mean age of 43.6 years, 57% were women and 98% were German. On average, about half of the patients were married (SOMS: 53%; CON: 51%) and almost all had at least some high school education (SOMS: 98%; CON: 100%). Both groups were functionally equally impaired (SOMS: 53.4; CON: 54.1), but the SOMS group had been

Discussion

With this paper we aimed to contribute to the currently proposed revisions for the DSM-5 chapter of somatoform disorders. Ascribing physical symptoms solely to a medical condition is difficult, which is why we consider the current SSD's criteria as beneficial to previous definitions: the presence of MUS is not required and a variety of psychological and behavioral features are included [3]. As pointed out previously by our work group, physical and psychological disturbances should be classified

Conclusions

With our data we were able to evaluate the proposed SSD criteria in a cross-sectional study to assess their validity. There is a strong need to add specific symptoms to the current chapter of somatoform disorders since the pure existence of somatic symptoms does not justify the diagnosis of a mental disorder. In sum, our results support the inclusion of psychological and behavioral characteristics as diagnostic criteria [3], [51]. We could show that physical impairment is based on psychosocial

Conflict of Interest

The authors have no competing interests to report.

Acknowledgments

We thank the Schön Clinic and the University Medical Center Hamburg-Eppendorf which supported this research program.

References (55)

  • N Steinbrecher et al.

    Course and prediction of somatoform disorder and medically unexplained symptoms in primary care

    Gen Hosp Psychiat

    (Jul-Aug 2011)
  • C Hausteiner et al.

    Characteristics of oligosymptomatic versus polysymptomatic presentations of somatoform disorders in patients with suspected allergies

    J Psychosom Res

    (Sep 2010)
  • SS Taillefer et al.

    Psychological correlates of functional status in chronic fatigue syndrome

    J Psychosom Res

    (Dec 2002)
  • W Hiller et al.

    Causal symptom attributions in somatoform disorder and chronic pain

    J Psychosom Res

    (2010)
  • K Kroenke et al.

    Symptoms, syndromes, and the value of psychiatric diagnostics in patients who have functional somatic disorders

    Med Clin North Am

    (Jul 2006)
  • G Hanel et al.

    Depression, anxiety, and somatoform disorders: vague or distinct categories in primary care? Results from a large cross-sectional study

    J Psychosom Res

    (2009)
  • MC Watt et al.

    Anxiety sensitivity mediates the relationships between childhood learning experiences and elevated hypochondriacal concerns in young adulthood

    J Psychosom Res

    (Aug 2000)
  • DK Marcus

    The cognitive-behavioral model of hypochondriasis: misinformation and triggers

    J Psychosom Res

    (July 1999)
  • PJ de Jong et al.

    Hypochondriasis: the role of fear-confirming reasoning

    Behav Res Ther

    (Jan 1998)
  • J Jackson et al.

    Number of bodily symptoms predicts outcome more accurately than health anxiety in patients attending neurology, cardiology, and gastroenterology clinics

    J Psychosom Res

    (2006)
  • P Fink et al.

    Screening for somatization and hypochondriasis in primary care and neurological in-patients: a seven-item scale for hypochondriasis and somatization

    J Psychosom Res

    (1999)
  • W Rief et al.

    A new approach to assess illness behaviour

    J Psychosom Res

    (2003)
  • B Löwe et al.

    Comparative validity of three screening questionnaires for DSM-IV depressive disorders and physicians' diagnoses

    J Affect Disord

    (2004)
  • K Voigt et al.

    Towards positive diagnostic criteria: a systematic review of somatoform disorder diagnoses and suggestions for future classification

    J Psychosom Res

    (2010)
  • P Fink

    Surgery and medical treatment in persistent somatizing patients

    J Psychosom Res

    (1992)
  • S Groben et al.

    Somatoform disorders and causal attributions in patients with suspected allergies: do somatic causal attributions matter?

    J Psychosom Res

    (Mar 2011)
  • RC Smith et al.

    Exploration of DSM-IV criteria in primary care patients with medically unexplained symptoms

    Psychosom Med

    (2005)
  • Cited by (33)

    • Construct validity and clinical utility of current research criteria of DSM-5 somatic symptom disorder diagnosis in patients with fibromyalgia syndrome

      2015, Journal of Psychosomatic Research
      Citation Excerpt :

      The DSM 5 SSD workgroup postulated that clinicians should diagnose and treat SSD because successful treatment options (psychotherapy, psychotropic drugs) are available [2]. Early US studies provided evidence concerning feasibility [3], reliability [4], validity [5–7] and clinical utility [5,7,3] of the SSD diagnostic category. A gold standard method of diagnosis, a structured interview of the SSD criteria, does not yet exist.

    • Dysfunctional illness perception and illness behaviour associated with high somatic symptom severity and low quality of life in general hospital outpatients in China

      2014, Journal of Psychosomatic Research
      Citation Excerpt :

      The model proposes that in facing somatic symptoms, individuals develop a certain cognitive and emotional illness representation that motivates corresponding illness behaviour to cope with these symptoms. Some Western studies have found strong evidence supporting the use of some psychological variables to identify people with high somatic symptom severity (SSS) [6–10]. Some Western studies also demonstrate that psychobehavioural features may influence the quality of life (QoL) of patients with somatic complaints [7,11–14].

    View all citing articles on Scopus
    1

    Present address: The Pennsylvania State University, Altoona, USA.

    View full text